Nothing Special   »   [go: up one dir, main page]

HK1170673A1 - Compositions and methods for increasing blood platelet levels in humans - Google Patents

Compositions and methods for increasing blood platelet levels in humans

Info

Publication number
HK1170673A1
HK1170673A1 HK12111489.1A HK12111489A HK1170673A1 HK 1170673 A1 HK1170673 A1 HK 1170673A1 HK 12111489 A HK12111489 A HK 12111489A HK 1170673 A1 HK1170673 A1 HK 1170673A1
Authority
HK
Hong Kong
Prior art keywords
humans
compositions
methods
blood platelet
increasing blood
Prior art date
Application number
HK12111489.1A
Other languages
English (en)
Inventor
Robert E Desjardins
Rudolph Lucek
Original Assignee
Akarx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akarx Inc filed Critical Akarx Inc
Publication of HK1170673A1 publication Critical patent/HK1170673A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK12111489.1A 2006-08-08 2012-11-13 Compositions and methods for increasing blood platelet levels in humans HK1170673A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83633406P 2006-08-08 2006-08-08

Publications (1)

Publication Number Publication Date
HK1170673A1 true HK1170673A1 (en) 2013-03-08

Family

ID=39082656

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12111489.1A HK1170673A1 (en) 2006-08-08 2012-11-13 Compositions and methods for increasing blood platelet levels in humans

Country Status (9)

Country Link
US (2) US20080039475A1 (es)
EP (2) EP2056826B1 (es)
JP (3) JP2010500361A (es)
AU (2) AU2007284644B2 (es)
CA (1) CA2660283C (es)
ES (2) ES2452032T3 (es)
HK (1) HK1170673A1 (es)
IL (4) IL196897A (es)
WO (1) WO2008021283A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2472711C (en) * 2002-01-18 2012-03-20 Yamanouchi Pharmaceutical Co., Ltd. 2-acylaminothiazole derivative or salt thereof
EP2464352A1 (en) * 2009-08-14 2012-06-20 Eisai Inc. Use of e5501 for stimulating platelet production
CN112022825B (zh) * 2020-08-24 2024-03-22 瑞阳制药股份有限公司 马来酸阿伐曲泊帕片剂及其制备方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5330998A (en) * 1988-03-08 1994-07-19 Pfizer Inc. Thiazolidinedione derivatives as hypoglycemic agents
US5256675A (en) * 1989-08-07 1993-10-26 Fujisawa Pharmaceutical Co., Ltd. Thiazole derivatives, processes for production thereof and pharmaceutical compositions comprising the same
IE68593B1 (en) * 1989-12-06 1996-06-26 Sanofi Sa Heterocyclic substituted acylaminothiazoles their preparation and pharmaceutical compositions containing them
FR2677356B1 (fr) * 1991-06-05 1995-03-17 Sanofi Sa Derives heterocycliques d'acylamino-2 thiazoles-5 substitues, leur preparation et compositions pharmaceutiques en contenant.
US5250732A (en) * 1991-07-18 1993-10-05 Genentech, Inc. Ketamine analogues for treatment of thrombocytopenia
GB9126677D0 (en) * 1991-12-16 1992-02-12 Johnson Matthey Plc Improvements in chemical compounds
DE59401177D1 (de) * 1993-04-08 1997-01-16 Abb Management Ag Misch- und Flammenstabilisierungseinrichtung in einer Brennkammer mit Vormischverbrennung
WO1996028447A1 (fr) * 1995-03-09 1996-09-19 Kyowa Hakko Kogyo Co., Ltd. Derives de pyrrolocarbazole
CA2218479C (en) * 1995-04-28 2008-01-15 Banyu Pharmaceutical Co., Ltd. 1,4-di-substituted piperidine derivatives
JP3059218B2 (ja) * 1995-06-07 2000-07-04 グラクソ・グループ・リミテッド トロンボポエチン受容体に結合するペプチドおよび化合物
US5963666A (en) * 1995-08-18 1999-10-05 International Business Machines Corporation Confusion matrix mediated word prediction
WO1997014704A1 (fr) * 1995-10-17 1997-04-24 Suntory Limited Medicament contre la thrombopenie
US5932546A (en) * 1996-10-04 1999-08-03 Glaxo Wellcome Inc. Peptides and compounds that bind to the thrombopoietin receptor
US6187797B1 (en) * 1996-12-23 2001-02-13 Dupont Pharmaceuticals Company Phenyl-isoxazoles as factor XA Inhibitors
AU762245B2 (en) * 1998-09-18 2003-06-19 Vertex Pharmaceuticals Incorporated Inhibitors of p38
ATE315390T1 (de) * 1998-11-17 2006-02-15 Smithkline Beecham Corp Zyklische polyamine zur behandlung der thrombozytopenie
TWI284639B (en) * 2000-01-24 2007-08-01 Shionogi & Co A compound having thrombopoietin receptor agonistic effect
GB0028383D0 (en) * 2000-11-21 2001-01-03 Novartis Ag Organic compounds
WO2002062775A1 (fr) * 2001-02-02 2002-08-15 Yamanouchi Pharmaceutical Co., Ltd. Dérivé de 2-acylaminothiazole ou son sel
US7199124B2 (en) * 2001-02-02 2007-04-03 Takeda Pharmaceutical Company Limited JNK inhibitor
CA2472711C (en) * 2002-01-18 2012-03-20 Yamanouchi Pharmaceutical Co., Ltd. 2-acylaminothiazole derivative or salt thereof
EP2471533A1 (en) * 2002-06-27 2012-07-04 Novo Nordisk A/S Aryl carbonyl derivatives as therapeutic agents
AU2003268687A1 (en) * 2002-09-30 2004-04-19 Yamanouchi Pharmaceutical Co., Ltd. Novel salt of 2-acylaminothiazole derivative
CA2523125A1 (en) * 2003-03-25 2004-10-14 Vertex Pharmaceuticals Incorporated Thiazoles useful as inhibitors of protein kinases
EP1647553A4 (en) * 2003-07-17 2008-12-31 Astellas Pharma Inc 2-ACYLAMINOTHIAZOL DERIVATIVE OR SALT THEREOF
EP1655291B1 (en) * 2003-08-12 2016-08-03 Shionogi & Co., Ltd. Compounds having thrombopoietin receptor agonism
CN101355968A (zh) * 2005-11-08 2009-01-28 安斯泰来制药有限公司 治疗血小板减少的组合物和方法

Also Published As

Publication number Publication date
WO2008021283A3 (en) 2008-12-11
ES2470333T3 (es) 2014-06-23
EP2452674A2 (en) 2012-05-16
US20080039475A1 (en) 2008-02-14
AU2007284644B2 (en) 2011-09-01
IL240323A (en) 2016-05-31
JP2015221806A (ja) 2015-12-10
IL245911A0 (en) 2016-07-31
EP2452674A3 (en) 2012-05-30
IL240322A0 (en) 2015-09-24
WO2008021283A2 (en) 2008-02-21
US20110224226A1 (en) 2011-09-15
EP2452674B1 (en) 2014-03-26
JP2010500361A (ja) 2010-01-07
AU2011253775A1 (en) 2011-12-22
EP2056826A4 (en) 2009-09-09
AU2011253775B2 (en) 2014-02-13
EP2056826A2 (en) 2009-05-13
IL196897A (en) 2015-08-31
ES2452032T3 (es) 2014-03-31
JP2013047257A (ja) 2013-03-07
CA2660283C (en) 2014-11-18
CA2660283A1 (en) 2008-02-21
EP2056826B1 (en) 2014-01-08
IL240323A0 (en) 2015-09-24
AU2007284644A1 (en) 2008-02-21
IL196897A0 (en) 2011-08-01
JP6258264B2 (ja) 2018-01-10

Similar Documents

Publication Publication Date Title
IL195619A0 (en) Compositions and methods for joininig non-conjoined iumens
HK1137670A1 (en) Compositions and methods for arthrodetic procedures
EP1973986A4 (en) COMPLEX BIOACTIVE COMPOSITIONS AND METHODS OF USE
ZA200900388B (en) Compositions and methods for the treatment of mucositis
HK1125868A1 (en) Compositions and methods for treating bone
EP2101731A4 (en) PROCESSES AND COMPOSITIONS WITH END OXIFES
EP2046936A4 (en) BIOCIDAL COMPOSITIONS AND METHODS
ZA200808431B (en) Fungicidal compositions and methods of using the same
EP2109673A4 (en) METHOD AND DEVICE FOR REINFORCED PROTEIN EXPRESSION AND CLEANING
GB0721291D0 (en) Methods and compositions
EP2088865A4 (en) METHODS AND COMPOSITIONS AROUND GUGGULPHOSPHOLIPIDS
GB0617171D0 (en) Novel compositions and methods
EP2076281A4 (en) STABILIZING ALKYLGLYCOSIDIC COMPOSITIONS AND METHODS THEREOF
IL196411A0 (en) Anti-cocaine compositions and treatment
PT2061458E (pt) Composições de topiramato e métodos para a sua utilização
ZA200707490B (en) Methods and compositions for modulatiing vascular integrity
GB0719526D0 (en) Compositions and methods
EP2029132A4 (en) ANTIHISTAMINE COMPOSITIONS AND THEIR USE
HK1129596A1 (en) Methods and compositions for treating disease
IL245911A0 (en) Compositions and methods for increasing the level of blood platelets in humans
PL2132251T3 (pl) Kompozycja i sposób
GB0625208D0 (en) Composition and method
GB0620695D0 (en) Composition and methods for the treatment of nurdegenerative disease
GB0718271D0 (en) Lubricant formulations and methods
GB0600261D0 (en) Composition and method